The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJpmorgan Clav Regulatory News (JCH)

Share Price Information for Jpmorgan Clav (JCH)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 724.00
Bid: 722.00
Ask: 726.00
Change: 6.00 (0.84%)
Spread: 4.00 (0.554%)
Open: 722.00
High: 724.00
Low: 720.00
Prev. Close: 718.00
JCH Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

20 Apr 2017 14:17

RNS Number : 8942C
JPMorgan Claverhouse IT PLC
20 April 2017
 

TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi

1. Identity of the issuer or the underlying issuerof existing shares to which voting rights areattached: ii

JPMorgan Claverhouse Investment Trust plc

2 Reason for the notification (please tick the appropriate box or boxes):

An acquisition or disposal of voting rights

An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached

An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments

An event changing the breakdown of voting rights

YES

Other (please specify):

3. Full name of person(s) subject to thenotification obligation: iii

Chase Nominees Limited

4. Full name of shareholder(s)  (if different from 3.):iv

Chase Nominees Limited

5. Date of the transaction and date onwhich the threshold is crossed orreached: v

19th April 2017

6. Date on which issuer notified:

19th April 2017

7. Threshold(s) that is/are crossed orreached: vi, vii

3%

 

8. Notified details:

A: Voting rights attached to shares viii, ix

Class/type ofshares

if possible usingthe ISIN CODE

Situation previousto the triggeringtransaction

Resulting situation after the triggering transaction

NumberofShares

NumberofVotingRights

Numberof shares

Number of votingrights

% of voting rights x

Direct

Direct xi

Indirect xii

Direct

Indirect

Ordinary shares

GB0000342218

20,515,479

0

9,334,907

9,334,907

17.10%

B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financialinstrument

Expirationdate xiii

Exercise/Conversion Period xiv

Number of votingrights that may beacquired if theinstrument isexercised/ converted.

% of votingrights

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi

Resulting situation after the triggering transaction

Type of financialinstrument

Exercise price

Expiration date xvii

Exercise/Conversion period xviii

Number of voting rights instrument refers to

 

% of voting rights xix, xx

 

Nominal

Delta

Total (A+B+C)

Number of voting rights

Percentage of voting rights

9,334,907

17.10%

 

9. Chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held, if applicable: xxi

Chase Nominees Limited announces that J.P. Morgan Trustee & Administration Services Limited has a notifiable interest in 9,334,907 Ordinary shares. These shares are held on behalf of participants in the JPMorgan investment trust savings products. J.P. Morgan Trustee & Administration Services Limited has a notifiable interest in these shares because, in certain circumstances and subject to certain limitations agreed with the Takeover Panel to ensure compliance with the Takeover Code, JPMorgan is entitled to exercise the voting rights attached to the Ordinary shares if the relevant plan participants do not do so.

 

JPMorgan is now entitled to exercise the voting rights attached to these Ordinary shares, as these shares have not been voted by the participants in the JPMorgan investment trust savings products in respect of the Company's 2017 Annual General Meeting to be held on Friday 21st April 2017. This entitlement will cease following the conclusion of the Company's 2017 Annual General Meeting.

Proxy Voting:

10. Name of the proxy holder:

N/A

11. Number of voting rights proxy holder will cease to hold:

N/A

12. Date on which proxy holder will cease to hold voting rights:

N/A

13. Additional information:

N/A

14. Contact name:

Jonathan Latter

15. Contact telephone number:

020 7742 4000

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLEADLEAFSXEFF
Date   Source Headline
26th Sep 202311:04 amRNSNet Asset Value(s)
25th Sep 202312:36 pmRNSGearing Announcement
25th Sep 202312:07 pmRNSNet Asset Value(s)
22nd Sep 20235:07 pmRNSTransaction in Own Shares
22nd Sep 202311:03 amRNSNet Asset Value(s)
21st Sep 202311:15 amRNSNet Asset Value(s)
20th Sep 20235:17 pmRNSTransaction in Own Shares
20th Sep 202310:38 amRNSNet Asset Value(s)
19th Sep 20235:07 pmRNSTransaction in Own Shares
19th Sep 202310:36 amRNSNet Asset Value(s)
19th Sep 20237:00 amRNSKepler Trust Intelligence: New Research
18th Sep 202312:52 pmRNSGearing Announcement
18th Sep 202311:07 amRNSNet Asset Value(s)
15th Sep 20235:43 pmRNSDirector/PDMR Shareholding
15th Sep 202311:31 amRNSNet Asset Value(s)
14th Sep 202311:07 amRNSNet Asset Value(s)
13th Sep 202311:50 amRNSTen Largest Investments
13th Sep 202310:58 amRNSNet Asset Value(s)
12th Sep 202310:58 amRNSNet Asset Value(s)
11th Sep 202312:53 pmRNSGearing Announcement
11th Sep 202310:58 amRNSNet Asset Value(s)
8th Sep 202311:11 amRNSNet Asset Value(s)
7th Sep 202310:52 amRNSNet Asset Value(s)
5th Sep 20235:12 pmRNSTransaction in Own Shares
5th Sep 202310:56 amRNSNet Asset Value(s)
4th Sep 202312:36 pmRNSGearing Announcement
4th Sep 202310:40 amRNSNet Asset Value(s)
1st Sep 20235:08 pmRNSTransaction in Own Shares
1st Sep 202312:50 pmRNSNet Asset Value(s)
31st Aug 202311:14 amRNSNet Asset Value(s)
30th Aug 202310:58 amRNSNet Asset Value(s)
29th Aug 20231:31 pmRNSGearing announcement
29th Aug 202312:26 pmRNSNet Asset Value(s)
25th Aug 202311:04 amRNSNet Asset Value(s)
24th Aug 202310:58 amRNSNet Asset Value(s)
23rd Aug 202310:57 amRNSNet Asset Value(s)
22nd Aug 202310:41 amRNSNet Asset Value(s)
21st Aug 202312:28 pmRNSGearing Announcement
21st Aug 202310:30 amRNSNet Asset Value(s)
18th Aug 202310:43 amRNSNet Asset Value(s)
17th Aug 202311:02 amRNSNet Asset Value(s)
16th Aug 202311:07 amRNSNet Asset Value(s)
16th Aug 20239:34 amRNSTen Largest Investments
15th Aug 202311:49 amRNSNet Asset Value(s)
14th Aug 202312:08 pmRNSGearing Announcement
14th Aug 202310:44 amRNSNet Asset Value(s)
11th Aug 202310:58 amRNSNet Asset Value(s)
10th Aug 202310:38 amRNSNet Asset Value(s)
10th Aug 20237:00 amRNSHalf-year Report
9th Aug 202311:19 amRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.